Cite
HARVARD Citation
Sha, Y. et al. (2022). PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo. Cancer letters. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sha, Y. et al. (2022). PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo. Cancer letters. p. . [Online].